| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
|
Chowdhury, Simon
|
|
|
19 |
5 |
p. 434-446
|
article
|
| 2 |
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer
|
McHugh, Deaglan
|
|
|
19 |
5 |
p. 447-456
|
article
|
| 3 |
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
|
Di Lorenzo, Giuseppe
|
|
|
19 |
5 |
p. e286-e298
|
article
|
| 4 |
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial
|
Marandino, L
|
|
|
19 |
5 |
p. 457-465
|
article
|
| 5 |
Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors
|
Pond, Gregory R.
|
|
|
19 |
5 |
p. 425-433
|
article
|
| 6 |
Combining Stereotactic Body Radiotherapy and Microwave Ablation Appears Safe and Feasible for Renal Cell Carcinoma in an Early Series
|
Blitzer, Grace C.
|
|
|
19 |
5 |
p. e313-e318
|
article
|
| 7 |
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
|
Pelloux-Prayer, Rémi
|
|
|
19 |
5 |
p. e326-e333
|
article
|
| 8 |
Editorial Board
|
|
|
|
19 |
5 |
p. A1
|
article
|
| 9 |
Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED Trial
|
Li, Eric V.
|
|
|
19 |
5 |
p. 388-395
|
article
|
| 10 |
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
|
Hijab, Adham
|
|
|
19 |
5 |
p. e299-e305
|
article
|
| 11 |
Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas
|
Costantini, Manuela
|
|
|
19 |
5 |
p. e280-e285
|
article
|
| 12 |
Impact of Lymphovascular Invasion on Overall Survival in Patients With Prostate Cancer Following Radical Prostatectomy: Stage-per-Stage Analysis
|
Jamil, Marcus
|
|
|
19 |
5 |
p. e319-e325
|
article
|
| 13 |
Performance of Indocyanine Green Fluorescence for Detecting Lymph Node Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis
|
Urabe, Fumihiko
|
|
|
19 |
5 |
p. 466.e1-466.e9
|
article
|
| 14 |
Pre-Implementation Assessment of the Acceptability of Using Circulating microRNAs for Follow-Up of Malignant Germ-Cell Tumors
|
Fern, Lorna A.
|
|
|
19 |
5 |
p. 381-387
|
article
|
| 15 |
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 Study
|
Szarek, Michael
|
|
|
19 |
5 |
p. 468.e1-468.e5
|
article
|
| 16 |
Renal Primitive Neuroectodermal Tumor With Inferior Vena Cava Thrombus: Case Series and Literature Review of a Rare but Challenging Entity
|
Xu, Chuxiao
|
|
|
19 |
5 |
p. e273-e279
|
article
|
| 17 |
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors
|
Morgans, Alicia K.
|
|
|
19 |
5 |
p. 467.e1-467.e11
|
article
|
| 18 |
Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study
|
Aras, Omer
|
|
|
19 |
5 |
p. 405-416
|
article
|
| 19 |
Stage Presentation, Care Patterns, Treatment Outcomes, and Impact of Radiotherapy on Overall Survival for Adrenocortical Carcinoma
|
Thomas, Justin J.
|
|
|
19 |
5 |
p. 417-424
|
article
|
| 20 |
Table of contents
|
|
|
|
19 |
5 |
p. A3-A6
|
article
|
| 21 |
The Diagnostic Value of FDG-PET/CT for Urachal Cancer
|
Stokkel, Laura E.
|
|
|
19 |
5 |
p. 373-380
|
article
|
| 22 |
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy
|
Rundo, Francesco
|
|
|
19 |
5 |
p. 396-404
|
article
|
| 23 |
Time to Resolution of Axitinib-Related Adverse Events After Treatment Interruption in Patients With Advanced Renal Cell Carcinoma
|
Rini, Brian I.
|
|
|
19 |
5 |
p. e306-e312
|
article
|
Journal description